Kreppel F - Search Results

1

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.

Nettelbeck DM, Leber MF, Altomonte J, Angelova A, Beil J, Berchtold S, Delic M, Eberle J, Ehrhardt A, Engeland CE, Fechner H, Geletneky K, Goepfert K, Holm PS, Kochanek S, Kreppel F, Krutzke L, Kühnel F, Lang KS, Marchini A, Moehler M, Mühlebach MD, Naumann U, Nawroth R, Nüesch J, Rommelaere J, Lauer UM, Ungerechts G. Nettelbeck DM, et al. Among authors: kreppel f. Viruses. 2021 Jul 21;13(8):1420. doi: 10.3390/v13081420. Viruses. 2021. PMID: 34452286 Free PMC article. Review.

2

Virotherapy Research in Germany: From Engineering to Translation.

Ungerechts G, Engeland CE, Buchholz CJ, Eberle J, Fechner H, Geletneky K, Holm PS, Kreppel F, Kühnel F, Lang KS, Leber MF, Marchini A, Moehler M, Mühlebach MD, Rommelaere J, Springfeld C, Lauer UM, Nettelbeck DM. Ungerechts G, et al. Among authors: kreppel f. Hum Gene Ther. 2017 Oct;28(10):800-819. doi: 10.1089/hum.2017.138. Hum Gene Ther. 2017. PMID: 28870120 Review.

3

From Virus to vector to medicine: Foreword by guest editors.

Kreppel F, Ehrhardt A. Kreppel F, et al. Virus Genes. 2017 Oct;53(5):673-674. doi: 10.1007/s11262-017-1503-6. Virus Genes. 2017. PMID: 28921483 No abstract available.

4

Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide.

Kreppel F, Kochanek S. Kreppel F, et al. Mol Ther. 2008 Jan;16(1):16-29. doi: 10.1038/sj.mt.6300321. Epub 2007 Oct 2. Mol Ther. 2008. PMID: 17912234 Free article. Review.

5

Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis.

Tolksdorf B, Zarif S, Eberle J, Hazini A, Dieringer B, Jönsson F, Kreppel F, Kurreck J, Fechner H. Tolksdorf B, et al. Among authors: kreppel f. J Mol Med (Berl). 2021 Sep;99(9):1279-1291. doi: 10.1007/s00109-021-02081-3. Epub 2021 May 24. J Mol Med (Berl). 2021. PMID: 34028599 Free PMC article.

6

Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors.

Kreppel F, Kochanek S. Kreppel F, et al. J Virol. 2004 Jan;78(1):9-22. doi: 10.1128/jvi.78.1.9-22.2004. J Virol. 2004. PMID: 14671083 Free PMC article.

7

Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector-Host Interactions.

Weklak D, Pembaur D, Koukou G, Jönsson F, Hagedorn C, Kreppel F. Weklak D, et al. Among authors: kreppel f. Viruses. 2021 Jul 2;13(7):1300. doi: 10.3390/v13071300. Viruses. 2021. PMID: 34372506 Free PMC article. Review.

8

High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.

Kron MW, Engler T, Schmidt E, Schirmbeck R, Kochanek S, Kreppel F. Kron MW, et al. Among authors: kreppel f. J Gene Med. 2011 Dec;13(12):648-57. doi: 10.1002/jgm.1629. J Gene Med. 2011. PMID: 22095925

9

miRNA-mediated silencing in hepatocytes can increase adaptive immune responses to adenovirus vector-delivered transgenic antigens.

Kron MW, Espenlaub S, Engler T, Schirmbeck R, Kochanek S, Kreppel F. Kron MW, et al. Among authors: kreppel f. Mol Ther. 2011 Aug;19(8):1547-57. doi: 10.1038/mt.2011.83. Epub 2011 May 10. Mol Ther. 2011. PMID: 21556053 Free PMC article.

10

Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors.

Kreppel F, Gackowski J, Schmidt E, Kochanek S. Kreppel F, et al. Mol Ther. 2005 Jul;12(1):107-17. doi: 10.1016/j.ymthe.2005.03.006. Mol Ther. 2005. PMID: 15963926 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters